Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, Australia

Original research
by
Lintzeris, Nicholas et al

Release Date

2021

Geography

Australia

Language of Resource

English

Full Text Available

Yes

Open Access / OK to Reproduce

No

Peer Reviewed

Yes

Objective

Describes Covid-related changed to treatment & preliminary analysis of the association with patients' substance use and well-being.

Findings/Key points

These preliminary findings suggest that the modified model of care continued to provide safe and effective treatment, during the pandemic. Notably, there was no association between more TAD and significant increases in substance use.

Design/methods

n=429 A pre-post comparison of treatment conditions and patient self-reported outcomes using data extracted from electronic medical records in the 5 months before (December 2019–April 2020) and after (May 2020–September 2020) changes were implemented in three public treatment services in South Eastern Sydney Local Health District.

Keywords

Evidence base
Harm reduction
Safer supply
Advocacy
About prescribers
Outcomes